SPR Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Cleveland, OH USA
Total Funding:$50.5M
Industry:Medical Equip
Founded:N/A
Lead Investor(s):NDI Healthcare Fund

Industry Ranking

Estimated Revenue & Financials

  • SPR Therapeutics's estimated annual revenue is currently $15.6M per year.
  • SPR Therapeutics received $25.0M in venture funding in September 2017.
  • SPR Therapeutics's estimated revenue per employee is $251,000
  • SPR Therapeutics's total funding is $50.5M.

Employee Data

  • SPR Therapeutics has 62 Employees.
  • SPR Therapeutics grew their employee count by 35% last year.
  • SPR Therapeutics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$243.2M969N/AN/A-N/A
#2
$32.6M1307%N/A-N/A
#3
$118.2M471N/AN/A-N/A
#4
$368M1466N/AN/A4.2/5N/A
#5
$33.6M134N/AN/A-N/A
#6
$95.9M382N/AN/A-N/A
#7
$9.8M3918%N/A-N/A
#8
$6.3M25N/AN/A-N/A
#9
$11.3M45N/AN/A-N/A
#10
$11.3M45N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

SPR Therapeutics is committed to improving the lives of millions of pain sufferers with its peripheral nerve stimulation (PNS) platform technology poised to be the standard of care and ultimately, the treatment of choice for pain management. Led by a world-class team of scientists, physicians, and business professionals with a track record of commercializing innovative neurostimulation products, SPR's PNS therapy for acute and chronic pain management provides a non-narcotic, reversible, safe, effective and more affordable alternative to addictive opioid medications and invasive surgeries.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

62

Number of Employees

$15.6M

Revenue (est)

1

Current Jobs

35%

Employee Growth %

$50.5M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

SPR Therapeutics News

09/03/2019 - SPR Therapeutics' SPRINT Peripheral Nerve Stimulation ...

SPR Therapeutics' SPRINT Peripheral Nerve Stimulation System Significantly Reduces Opioid Use in Patients with Low Back Pain, Interim ...

09/08/2019 - Sacral Nerve Stimulation (SNS) Market growing by Increasing Market Share and Forecast 2026 with Top Key Players: Medtronic, LABORIE, Stimwave LLC, SunMed, Vygon SA

Medtronic; LABORIE; Stimwave LLC; SunMed; Vygon SA; Medline Industries, Inc.; NeuroMetrix, Inc.; SPR Therapeutics; NeuroSigma, Inc.; ...

09/03/2019 - What is healthtech?

SPR Therapeutics, developer of a peripheral nerve stimulation therapy platform designed to be an alternative to addictive opioid medications, ...

SPR Therapeutics Funding

DateAmountRoundLead InvestorsReference
2011-04-27$0.2MUndisclosedJumpStart VenturesArticle
2012-01-25$2.2MANDI MedicalArticle
2013-01-09$5.0MANDI Healthcare Fund, Public Square PartnersArticle
2014-06-12$3.9MUndisclosedArticle
2017-09-13$25.0MCArticle

SPR Therapeutics Executive Hires

DateNameTitleReference
2017-01-19Dave YoungbergVice President SalesArticle
2017-09-08Joseph BoggsSVP Research/DevelopmentArticle